NRX Pharmaceuticals, Inc. — All Filings
457 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
424B7
425
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | FORM 8-K | 0001437749-26-009611 | Mar 24, 2026 | Mar 23, 2026 |
| 10-K | FORM 10-K | 0001437749-26-009418 | Mar 23, 2026 | Dec 31, 2025 |
| DEFA14A | FORM DEFA14A | 0001437749-26-005362 | Feb 24, 2026 | — |
| ARS | ARS | 0001437749-26-005124 | Feb 23, 2026 | Dec 31, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-26-005119 | Feb 23, 2026 | Mar 23, 2026 |
| 4 | FORM 4 | 0001437749-26-004426 | Feb 17, 2026 | Jan 27, 2026 |
| 3 | FORM 3 | 0001437749-26-004425 | Feb 17, 2026 | Jan 27, 2026 |
| 8-K | FORM 8-K | 0001437749-26-004246 | Feb 17, 2026 | — |
| 8-K | FORM 8-K | 0001437749-26-004245 | Feb 17, 2026 | — |
| 424B5 | FORM 424B5 | 0001437749-26-004244 | Feb 17, 2026 | — |
| PRE 14A | FORM PRE 14A | 0001437749-26-004131 | Feb 13, 2026 | Mar 23, 2026 |
| 8-K | FORM 8-K | 0001437749-26-002682 | Feb 2, 2026 | Jan 27, 2026 |
| 8-K | FORM 8-K | 0001437749-26-001455 | Jan 16, 2026 | Jan 12, 2026 |
| 8-K | FORM 8-K | 0001437749-25-038835 | Dec 29, 2025 | Dec 18, 2025 |
| EFFECT | — | 9999999995-25-003879 | Dec 22, 2025 | — |
| 424B3 | FORM 424B3 | 0001437749-25-038563 | Dec 22, 2025 | — |
| S-3/A | FORM S-3/A | 0001437749-25-037734 | Dec 12, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-036452 | Nov 26, 2025 | Nov 20, 2025 |
| 8-K/A | FORM 8-K/A | 0001437749-25-036005 | Nov 21, 2025 | Sep 8, 2025 |
| 10-Q | FORM 10-Q | 0001437749-25-035210 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-031637 | Oct 23, 2025 | Oct 17, 2025 |
| 8-K | FORM 8-K | 0001437749-25-029907 | Sep 26, 2025 | Sep 24, 2025 |
| 8-K | FORM 8-K | 0001437749-25-028949 | Sep 12, 2025 | Sep 8, 2025 |
| 4 | — | 0001415889-25-024084 | Sep 10, 2025 | Apr 9, 2025 |
| 4 | — | 0001415889-25-024083 | Sep 10, 2025 | Apr 9, 2025 |
| 4 | — | 0001415889-25-024082 | Sep 10, 2025 | Apr 9, 2025 |
| 4 | — | 0001415889-25-024081 | Sep 10, 2025 | Apr 9, 2025 |
| 8-K | FORM 8-K | 0001437749-25-028567 | Sep 8, 2025 | Sep 2, 2025 |
| SCHEDULE 13G | — | 0001213900-25-079159 | Aug 21, 2025 | — |
| 3 | — | 0001213900-25-079145 | Aug 21, 2025 | Aug 18, 2025 |
| 8-K | FORM 8-K | 0001437749-25-027256 | Aug 18, 2025 | — |
| 424B5 | FORM 424B5 | 0001437749-25-027184 | Aug 18, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-027167 | Aug 18, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-027059 | Aug 15, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | — | 0000950170-25-109219 | Aug 14, 2025 | — |
| NT 10-Q | FORM NT 10-Q | 0001437749-25-026997 | Aug 14, 2025 | Jun 30, 2025 |
| RW | FORM RW | 0001437749-25-021178 | Jun 24, 2025 | — |
| S-3 | FORM S-3 | 0001437749-25-020924 | Jun 20, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-019803 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | FORM 8-K | 0001437749-25-018000 | May 21, 2025 | May 15, 2025 |
| SCHEDULE 13G | — | 0000950170-25-072852 | May 15, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-017252 | May 15, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001437749-25-016272 | May 13, 2025 | — |
| 10-K/A | FORM 10-K/A | 0001437749-25-013874 | Apr 30, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-25-012303 | Apr 17, 2025 | — |
| 424B3 | FORM 424B3 | 0001437749-25-012301 | Apr 17, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-008777 | Mar 21, 2025 | Mar 17, 2025 |
| 10-K | FORM 10-K | 0001437749-25-007743 | Mar 14, 2025 | Dec 31, 2024 |
| D | — | 0001437749-25-006621 | Mar 7, 2025 | — |
| 424B3 | FORM 424B3 | 0001437749-25-004520 | Feb 20, 2025 | — |